James R. Gruber

Chief Financial Officer, Eton Pharmaceuticals, Inc.

Companies

Eton Pharmaceuticals, Inc.Chief financial officer Apr 14, 2022 to Jun 1, 2026¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Eton Pharmaceuticals, Inc. ETON213,420 shares²$10.6M at $49.62Jan 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 14, 2026Shares withheld for tax 2,293 shares at $15.47 of Eton Pharmaceuticals, Inc.²
Dec 12, 2025Shares withheld for tax 4,542 shares at $16.99 of Eton Pharmaceuticals, Inc.³
Aug 20, 2025Sold 2,631 shares at $16.02 of Eton Pharmaceuticals, Inc.⁴
Aug 19, 2025Sold 39,082 shares at $16.16 of Eton Pharmaceuticals, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREton Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGAREton Pharmaceuticals, Inc. shares after the filing of Jan 14, 2026
3
SEC EDGARForm 4 filed Dec 12, 2025
4
SEC EDGARForm 4 filed Aug 20, 2025